RECOVER Kids Study at NYU Langone

Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions:
    Covid-19
  • Age: Between 0 Year(s) - 25 Year(s)
  • Gender: Male or Female
  • Other Inclusion Criteria:
      Infected Individuals:
    1. Individuals less than 26 years of age meeting WHO criteria for suspected, probable or confirmed SARS-CoV-2 infection on or after March 1, 2020.
      Uninfected Individuals:
    1. Individuals less than 26 years of age who have never met any of the WHO criteria for suspected, probable or confirmed SARS-CoV-2 infection.
      Note:
    • The primary caregiver, preferably the biological parent of the child (or children) enrolled in the pediatric PASC cohort, when possible, may provide consent to participate in prospective data and biological sample collection as specified in the protocol procedures as a member of a caregiver/child dyad.
    • If the caregiver is a biological parent of the child, the other biological parent may provide consent to participate in prospective biospecimen sample collection.

You may not be eligible for this study if the following are true:

    1. Any child, young adult, or caregiver who in the opinion of the site investigator may be at increased risk of adverse events during participation in the study, or who may not be able to complete study procedures due to co-morbid disease or disability.
    2. Any young adult age 18-25 who lacks capacity to provide consent.
    3. Any child, young, adult, or caregiver with co-morbid illness with expected survival < 2 years.
    4. Currently enrolled in the study: "Understanding the Long-term Impact of COVID-19 in Adults."



If you are registered as a volunteer, please log in to contact the study team/express interest in this study.

Contact the research team to learn more about this study.

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.